ArticleFrontiers in endocrinology2025
Study on differentiating benign and malignant thyroid nodules based on CT multi-phase artificial intelligence models.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Bibliometric and Latent Dirichlet Allocation (LDA) analysis of artificial intelligence for thyroid nodules.Frontiers in endocrinology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The rising global incidence of thyroid nodules necessitates improved non-invasive methods for differentiating benign from malignant lesions. However, research on artificial intelligence (AI) models using multiphase CT imaging to differentiate benign from malignant thyroid nodules is limited. Methods: This retrospective study analyzed multiphase CT data (noncontrast, arterial, and venous phases) from 604 patients with thyroid nodules confirmed by postoperative pathology. We developed and compared multiple machine learning and deep learning models using extracted radiomics features, raw 3D DICOM data, and key clinical factors (sex, age, thyroglobulin and thyrotropin levels). Model performance was evaluated using receiver operating characteristic (ROC) analysis, and Gradient-weighted Class Activation Mapping (Grad-CAM) was used for visualization. Results: Models incorporating imaging data significantly outperformed a clinical-only model (AUC = 0.811). Nomograms combining either a radiomics score (Rad-Score) or a deep learning score (AI-Score) with clinical data demonstrated the highest diagnostic accuracy. The nomogram based on Rad-Score and clinical data achieved a peak AUC of 0.885. Similarly, the AI-Score-based nomogram reached an AUC of 0.881. Both integrated approaches proved superior to models relying on a single data type. Conclusions: AI models integrating multiphase CT radiomics or deep learning features with clinical data provide a robust and highly accurate approach for differentiating benign from malignant thyroid nodules. These integrated models show significant potential for improving clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.